MRM (MEDIROM Healthcare Technologies) Piotroski F-Score: 6 (As of Jun. 24, 2026) — 50% Above Median


MRM MEDIROM Healthcare Technologies Inc MRM
53 GF Score
Price $1.07
GF Value $4.08
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MEDIROM Healthcare Technologies Piotroski F-Score?

MEDIROM Healthcare Technologies MRM -4.43% 53 Piotroski F-Score is 6 as of Jun. 24, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.08 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 95 Personal Services companies, MEDIROM Healthcare Technologies ranks better than 71.58% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MEDIROM Healthcare Technologies has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for MEDIROM Healthcare Technologies's Piotroski F-Score or its related term are showing as below:

MRM' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 6

During the past 7 years, the highest Piotroski F-Score of MEDIROM Healthcare Technologies was 6. The lowest was 3. And the median was 4.

MEDIROM Healthcare Technologies  (NAS:MRM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


MEDIROM Healthcare Technologies Piotroski F-Score Related Terms


MEDIROM Healthcare Technologies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for MEDIROM Healthcare Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDIROM Healthcare Technologies Piotroski F-Score Chart

MEDIROM Healthcare Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial 3.00 4.00 5.00 3.00 6.00

MEDIROM Healthcare Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.00 0.00 6.00 0.00

MRM vs DROR, CLIK, EJH: Piotroski F-Score Comparison

For the Personal Services subindustry, MEDIROM Healthcare Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDIROM Healthcare Technologies Piotroski F-Score vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where MEDIROM Healthcare Technologies's Piotroski F-Score falls into.


MRM
53GF Score
MEDIROM Healthcare Technologies Inc MRM
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was $0.97 Mil.
Cash Flow from Operations was $-8.66 Mil.
Revenue was $53.96 Mil.
Gross Profit was $14.60 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was (47.57 + 52.6) / 2 = $50.085 Mil.
Total Assets at the begining of this year (Dec23) was $47.57 Mil.
Long-Term Debt & Capital Lease Obligation was $13.34 Mil.
Total Current Assets was $17.59 Mil.
Total Current Liabilities was $27.19 Mil.
Net Income was $0.80 Mil.

Revenue was $47.42 Mil.
Gross Profit was $10.90 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was (50.012 + 47.57) / 2 = $48.791 Mil.
Total Assets at the begining of last year (Dec22) was $50.01 Mil.
Long-Term Debt & Capital Lease Obligation was $16.57 Mil.
Total Current Assets was $12.22 Mil.
Total Current Liabilities was $24.73 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MEDIROM Healthcare Technologies's current Net Income (TTM) was 0.97. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MEDIROM Healthcare Technologies's current Cash Flow from Operations (TTM) was -8.66. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=0.967/47.57
=0.02032794

ROA (Last Year)=Net Income/Total Assets (Dec22)
=0.802/50.012
=0.01603615

MEDIROM Healthcare Technologies's return on assets of this year was 0.02032794. MEDIROM Healthcare Technologies's return on assets of last year was 0.01603615. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

MEDIROM Healthcare Technologies's current Net Income (TTM) was 0.97. MEDIROM Healthcare Technologies's current Cash Flow from Operations (TTM) was -8.66. ==> -8.66 <= 0.97 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=13.339/50.085
=0.26632724

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=16.568/48.791
=0.33957082

MEDIROM Healthcare Technologies's gearing of this year was 0.26632724. MEDIROM Healthcare Technologies's gearing of last year was 0.33957082. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=17.593/27.185
=0.64715836

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=12.215/24.73
=0.49393449

MEDIROM Healthcare Technologies's current ratio of this year was 0.64715836. MEDIROM Healthcare Technologies's current ratio of last year was 0.49393449. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

MEDIROM Healthcare Technologies's number of shares in issue this year was 5.852. MEDIROM Healthcare Technologies's number of shares in issue last year was 5.167. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=14.604/53.956
=0.27066499

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=10.896/47.422
=0.22976677

MEDIROM Healthcare Technologies's gross margin of this year was 0.27066499. MEDIROM Healthcare Technologies's gross margin of last year was 0.22976677. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=53.956/47.57
=1.13424427

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=47.422/50.012
=0.94821243

MEDIROM Healthcare Technologies's asset turnover of this year was 1.13424427. MEDIROM Healthcare Technologies's asset turnover of last year was 0.94821243. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+1+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MEDIROM Healthcare Technologies has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
MEDIROM Healthcare Technologies (MRM) has a Piotroski F-Score of 6 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MEDIROM Healthcare Technologies and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, MEDIROM Healthcare Technologies' Piotroski F-Score has ranged from 3.00 to 6.00. According to the industry distribution chart, MEDIROM Healthcare Technologies ranks #27 out of 95 companies in the Personal Services industry, placing it in the top 28.4%.
Is MEDIROM Healthcare Technologies' Piotroski F-Score too high?
MEDIROM Healthcare Technologies' current Piotroski F-Score of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 6.00. The Personal Services industry median Piotroski F-Score is 5.00. MEDIROM Healthcare Technologies' value of 6 is 20% above this industry median. Based on the distribution chart, MEDIROM Healthcare Technologies ranks #27 out of 95 companies in the Personal Services industry, which is above the industry midpoint. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' Piotroski F-Score compare to DROR and CLIK?
According to the Personal Services industry distribution chart, MEDIROM Healthcare Technologies ranks #27 out of 95 companies for Piotroski F-Score. This puts MEDIROM Healthcare Technologies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. MEDIROM Healthcare Technologies' value of 6 is 20% above this benchmark. Historically, MEDIROM Healthcare Technologies' own Piotroski F-Score has ranged from 3.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, MEDIROM Healthcare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Personal Services company?
The median Piotroski F-Score among Personal Services companies is 5.00, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDIROM Healthcare Technologies's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MEDIROM Healthcare Technologies and its competitors. For the Personal Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDIROM Healthcare Technologies's current Piotroski F-Score is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.08, compared to a current price of $1.07 — trading 73.8% below its estimated fair value. The current Piotroski F-Score is 6, which is 50% above median its 10-year median of 4.00 and 20% above the Personal Services industry median of 5.00. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current Piotroski F-Score is 6 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?

Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued. The current stock price of $1.07 is trading 73.8% below its estimated GF Value™ of $4.08. GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.

Key valuation signals for MRM:

  • Piotroski F-Score: 6 (50% above median its 10-year median of 4.00)
  • GF Value™: $4.08 vs. price of $1.07 (73.8% below fair value)
  • GF Score™: 53/100 with 8 warning signs
  • Industry Position: 20% above the Personal Services median (#27 of 95)

No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDIROM Healthcare Technologies Business Description

Address 2-3-1 Daiba, 16th Floor, Tradepia Odaiba, Minato-ku, Tokyo, JPN, 135-0091
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score

Get the complete analysis for MRM

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$4.08
GF Value